MERCK THE FDA AND THE VIOXX RECALL CASE STUDY ANALYSIS

The Ethical Considerations Clearly, the objective to regain and maintain leadership position in the pharmaceutical industry was paramount to Merck than getting a safe product to the market. But the market for it was insignificant. With declining fortune, Merck found DTC irresistible and relied on it heavily to shore up its market share and to remain competitive. The antagonists argue further that the huge amount of money that pharmaceutical companies expend on DTC advertising could make prescription drugs more expensive to the consumers. COX-2 inhibitors are the newest form of nonsteroidal anti-inflammatory drugs NSAIDs and Vioxx, as one of them, was developed to overcome the stomach irritation and gastric bleeding associated with older NSAIDs with COX-1 and Cox-2 inhibitors, which include aspirin, ibuprofen, and naproxen to treat people who are in need of long-term pain relief. The outcome was that even though Vioxx patients showed less stomach damage, there is more blood clot problems than drugs in the naproxen group with five times higher risk of heart attack. Retrieved May 22, , from https:

Excluding patients with high risk of heart problem, the study gave some patients high doses of Vioxx and precluded them from taking aspirin. It is pertinent to say only United States has embraced DTC advertising of prescription dugs has never been permitted legally in Europe and it is banned outright in Canada Green, In a situation whereby FDA as the regulator is on the pay of the pharmaceutical industry, it can be expected that the rules and the procedures would be compromised. Related Essays Pharmaceutical Industry and E. How to cite this page Choose cite format:

Case Study: Merck & Company: the Vioxx Recall

No direct-to-consumer drug ads: Related Essays Pharmaceutical Industry and E. The antagonists of DTC advertising however, are of the opinion that the advertising cannot provide enough or vioxz information that will enable the consumers to make appropriate drug choices Sullivan, This gap is therefore open to manipulation to the advantage of the marketer.

merck the fda and the vioxx recall case study analysis

Congress to ban direct-to-consumer DTC is supported by this author. This was the case particularly in the rdcall marketing of Vioxx which evidently was discovered to be dangerous to the consumers but which the company ignored as will be expatiated later in this paper.

  HMCTS BUSINESS PLAN 2016

But the market for it was insignificant. InMerck wanted to prove whether Vioxx can reduce colon polyps.

How to cite this page Choose cite format: Literature Review Dissertation chapter: In a situation whereby FDA as the regulator is on the pay of the pharmaceutical industry, it can be expected that the rules and the procedures would be compromised. Surprisingly, Merck would ignore the recommendation only to be forced to include a warning label that highlight the fewer stomach problems but to expressly include a warning about possibly more heart attacks and strokes Beauchamp et al, DTC advertising could also adversely affect the relationship between the doctor and the patient Beauchamp et al, Merck, looking for ways to entrench its market leadership threatened thd impending loss of patent, relied heavily on Vioxx to capture the painkiller drug market with which it hoped to shore up its profile and revenue.

It is hard to imagine that decision makers at all levels in Merck would ignore the disturbing information provided by their own VIGOR study. These include the competitiveness of very high magnitude that yhe in the pharmaceutical industry in the s and the dilemma that Merck faced as a result of a number of its patents that were due to expire.

The outcome was that anaysis though Vioxx patients showed less stomach damage, there is more blood clot problems than drugs in the naproxen group with five times higher risk of heart attack. The legal implications of the recall and the effect of an enactment of a analyzis by the Congress to prevent the use of DTC method of advertising will also be examined. The possibility that the knowledge gap would exist is very high especially among the less privileged members of the society.

Case Study: Merck & Company: the Vioxx Recall | Free Essays –

Excluding patients with high risk of heart problem, the study gave some patients high doses of Vioxx and precluded them from taking aspirin. The purpose of this paper is to make an exposition of issues that the recall case entailed including the ethical issues that were involved, and the propriety of DTC advertising method. Hidden in Plain Sight. The COX-2 medication was effective for treatment of arthritis and other pains without users being exposed to stomach damage by naproxen.

  CURRICULUM VITAE VZOR V ANGLICTINE

Retrieved May 22,from https: A limited time offer! Ethical Theory and Business. At introduction stage, both Merck and FDA acted unethically by speeding up the review process. The Ethical Considerations Vioxxx, the objective to regain and maintain leadership position in the pharmaceutical industry was paramount to Merck than getting a safe product to the market. Merck Ag Pharmaceutical Industry and E.

merck the fda and the vioxx recall case study analysis

Direct-to Consumer Advertising Direct-to-consumer advertising of pharmaceutical drugs which involves direct promotion of prescription drugs to patients and physicians has continued to generate a lot of controversies with regard to its an on the public health and on the relationships that exist between doctors casr their patients.

DTC advertisings offer a lot of information such that would require assistance from professionals to be properly evaluated by the consumer in order to make good choices. For this reason, it is hard to see how the elderly, children, and the less endowed who are vulnerable and susceptible to deceptive and marketing strategies can become more informed in making drug choices Greene, American Journal of Public Health Vol.

The huge market share and profits that go with such position propelled Merck to overlook essential findings that would have revealed the heart attack risks associated with Vioxx at research and development stages.

During this period, it was discovered by some researchers that COX-2 inhibitors such as Vioxx would interfere with enzymes that very likely to prevent cardiovascular disease. The belief through trials in Merck was that while Vioxx provides guarantee against stomach damage, there is no increased risk to the heart. That is why physicians and researchers should be made to disclose their pecuniary interest in any pharmaceutical company and in its drugs.